Proteomics Reveals Protein Profile Changes in Cyclooxygenase-2 Inhibitor-Treated Endometrial Cancer Cells
Authors:
- Cai JingtingCJCai Jingting
- Zhang YuZYZhang Yu
- 1 March 2009
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 19 (3) , 326-333
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Proteomics‐based identification of α‐enolase as a tumor antigen in non‐small lung cancerCancer Science, 2007
- Proteomic analysis of MCF‐7 breast cancer cell line exposed to mitogenic concentration of 17β‐estradiolProteomics, 2006
- Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancerBritish Journal of Cancer, 2006
- Selective inhibition of cyclooxygenase‐2 inhibits colon cancer cell adhesion to extracellular matrix by decreased expression of β1 integrinCancer Science, 2005
- Role of cyclooxygenase‐2 in immunomodulation and prognosis of endometrial carcinomaInternational Journal of Cancer, 2005
- Platelet cell-surface protein disulphide-isomerase mediated S-nitrosoglutathione consumptionBiochemical Journal, 2004
- Cyclooxygenase‐2 expression in endometrial carcinomaCancer, 2002
- 8-Iso-Prostaglandin F 2α Reduces Trophoblast Invasion and Matrix Metalloproteinase ActivityHypertension, 2000
- Endometrial CarcinomaNew England Journal of Medicine, 1996
- From structure to function: possible biological roles of a new widespread protein family binding hydrophobic ligands and displaying a nucleotide binding siteFEBS Letters, 1995